EKU2017.3: Chronic Obstructive Pulmonary Disease
Mar 23, 2018, 04:09 PM
Chronic Obstructive Pulmonary Disease (COPD) is the fifth leading cause of death in the UK.
This Essential Knowledge Update (EKU2017.3) podcast explores the 2017 GOLD (Global initiative for Obstructive Lung Disease) guidelines and the Cochrane review of Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroids (ICS). Its provides information on the diagnosis of COPD, including history, chest x-ray and spirometry, and treatment (including long-term oxygen therapy). It also highlights the COPD value pyramid which shows the cost effectiveness of different treatments for COPD.
This Essential Knowledge Update (EKU2017.3) podcast explores the 2017 GOLD (Global initiative for Obstructive Lung Disease) guidelines and the Cochrane review of Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroids (ICS). Its provides information on the diagnosis of COPD, including history, chest x-ray and spirometry, and treatment (including long-term oxygen therapy). It also highlights the COPD value pyramid which shows the cost effectiveness of different treatments for COPD.